Observational cross-sectional multicenter study about clinical effect of intermitent continuous glucose monitoring (Flash) in adult type 1 diabetes patients in an Spanish public health system.
Observational cross-sectional multicenter study about clinical effect of intermitent continuous glucose monitoring (Flash) in adult type 1 diabetes patients in an Spanish public health system. All clinical variables are gathered from chart review. Data analysis is conducted using SPSS statistic software. Results are presented as mean +/- SD values. A paired Student´s t-test or Wilconxon signed test were used fr the analysis differences. Comparison between proportions were analyzed using a chi-square test. A P value \<0.05 was considered statistically significant. The protocolo was apporved by the reference Castilla-La Mancha Public Health Service Ethic Commitee. All participants provided written consent.
Study Type
OBSERVATIONAL
Enrollment
1,121
Use of the device FreeStyle Libre, only commercialized system for intermitent continuous glucose monitoring.
La Mancha- Centro Hospital
Alcázar de San Juan, Ciudad Real, Spain
Santa Barbara Hospital
Puertollano, Ciudad Real, Spain
Virgen de Altagracia Hospital
Valdepeñas, Ciudad Real, Spain
Virgen del Prado Hospital
Talavera de la Reina, Toledo, Spain
HbA1c difference
Difference in HbA1c before initiating iCGM compared with HbA1c levels after one year of treatment.
Time frame: 1 year
Frequency of SBGM
Daily number of blood capilary test fot glycemia determination.
Time frame: 1 year
Adherence to Flash
Time of use of Flash glucose monitoring (% possible time of use)
Time frame: 1 year
TIR
Time in range (TIR, 3.9-10 mmol/L) of the interstitial glucose
Time frame: 1 year
TAR
Time above range (TAR, \>10 mmol/L) of the interstitial glucose
Time frame: 1 year
TBR
Time bellow range (TBR, \<3.9 mmol/L) of the interstitial glucose
Time frame: 1 year
%CV
Percentage of the variation coefficient (%, \>36% is considered high levels)
Time frame: 1 year
Body weight
Total corporal body weight (Kg)
Time frame: 1 year
Insulin dose
Daily insulin dose requirements (UI/Kg/d)
Time frame: 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Albacete University Hospital
Albacete, Spain
Obispo Rafael Torija, St.
Ciudad Real, Spain
Guadalajara University Hospital
Guadalajara, Spain
Toledo University Hospital
Toledo, Spain